LEUKEMIA, ACUTE MYELOID (AML)
Clinical trials for LEUKEMIA, ACUTE MYELOID (AML) explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, ACUTE MYELOID (AML) trials appear
Sign up with your email to follow new studies for LEUKEMIA, ACUTE MYELOID (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to tame tough leukemia
Disease control Not yet recruitingThis early-phase study tests adding tocilizumab to standard chemotherapy (venetoclax and azacitidine) for adults with acute myeloid leukemia who cannot handle strong treatment. The goal is to find the safest dose and see if the combination helps control the disease. Only 12 parti…
Matched conditions: LEUKEMIA, ACUTE MYELOID (AML)
Phase: PHASE1 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New immune booster aims to stop childhood cancer relapse after transplant
Disease control Not yet recruitingThis early-phase trial tests a new therapy called ThINKK in 12 children aged 2–12 who have had a stem cell transplant for leukemia or neuroblastoma. The therapy uses specially designed immune cells to help the body's natural killer cells better attack any remaining cancer cells. …
Matched conditions: LEUKEMIA, ACUTE MYELOID (AML)
Phase: PHASE1 • Sponsor: Michel Duval • Aim: Disease control
Last updated May 19, 2026 11:46 UTC